Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes. [electronic resource]
Producer: 20201015Description: 53-63 p. digitalISSN:- 1573-7241
- Acute Coronary Syndrome -- blood
- Aged
- Blood Platelets -- drug effects
- Female
- Humans
- Male
- Middle Aged
- P-Selectin -- metabolism
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- metabolism
- Prasugrel Hydrochloride -- therapeutic use
- Purinergic P2Y Receptor Antagonists -- therapeutic use
- Receptors, Proteinase-Activated -- metabolism
- Signal Transduction
- Ticagrelor -- therapeutic use
- Toll-Like Receptors -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.